812 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
ABBV AbbVie Inc. $95.37 $144.42B N/A
Article Searches
One of Your Stock Investments is Being Acquired: Now What? http://www.zacks.com/stock/news/775278/one-of-your-stock-investments-is-being-acquired-now-what?cid=CS-ZC-FT-value_investor-775278 Feb 20, 2020 - One of your companies gets a buyout offer and the shares soar. There might be different strategies for traders and investors on what to do next.
17 Consumer Groups and Unions Ask FTC to Block AbbVie's Acquisition of Allergan https://www.fool.com/investing/2020/02/18/17-consumer-groups-and-unions-ask-ftc-to-block-abb.aspx?source=iedfolrf0000001 Feb 18, 2020 - The groups are worried about reduced competition if the merger goes through.
The Keys to Successfully Timing the Markets - February 14, 2020 http://www.zacks.com/stock/news/765639/the-keys-to-successfully-timing-the-markets-february-14-2020?cid=CS-ZC-FT-retirement_ideas|market_timing_secrets-765639 Feb 14, 2020 - Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails http://www.zacks.com/stock/news/765605/pharma-stock-roundup-abbv-agn-post-q4-results-another-alzheimers-study-fails?cid=CS-ZC-FT-analyst_blog|stock_roundup-765605 Feb 14, 2020 - AbbVie (ABBV) and Allergan (AGN) announce Q4 results.
Top Stock Research Reports for AbbVie, Accenture, TOTAL & Others http://www.zacks.com/research-daily/760345/top-stock-research-reports-for-abbvie-accenture-total-others?cid=CS-ZC-FT-research_daily-760345 Feb 11, 2020 - Top Stock Research Reports for AbbVie, Accenture, TOTAL & Others
With Solid Fourth Quarter Results, AbbVie Shows That Its Growth Days Are Far From Over https://www.fool.com/investing/2020/02/11/with-solid-fourth-quarter-results-abbvie-shows-tha.aspx?source=iedfolrf0000001 Feb 11, 2020 - Despite Humira's declining international sales, AbbVie is still worth considering.
AbbVie Inc (ABBV) Q4 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/02/07/abbvie-inc-abbv-q4-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 Feb 07, 2020 - ABBV earnings call for the period ending December 31, 2019.
AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4322499-abbvie-inc-abbv-ceo-rick-gonzalez-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare Feb 07, 2020 - AbbVie Inc. (NYSE:ABBV) Q4 2019 Earnings Conference Call February 07, 2020 9:00 AM ET Company Participants Liz Shea - Vice President of Investor Relations Rick Gonzalez - Chairman of the Board & C
Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split http://www.zacks.com/stock/news/754444/pharma-stock-roundup-bmy-gsk-sny-q4-results-mrk-earnings-split?cid=CS-ZC-FT-analyst_blog|stock_roundup-754444 Feb 07, 2020 - Merck (MRK), Bristol Myers (BMY), Sanofi (SNY), Glaxo (GSK) and Novo Nordisk (NVO) announce Q4 results.
AbbVie (ABBV) Q4 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/754245/abbvie-abbv-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-754245 Feb 07, 2020 - AbbVie (ABBV) delivered earnings and revenue surprises of 0.45% and 0.03%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Pages: 123456...82

Page 1>